Pharmaceutical

Phebra, University of Wollongong partner to develop can...

Pharmaceutical firm Phebra has reached a new six-year collaboration agreement wi...

Sandoz concludes acquisition of Mycamine antifungal age...

Novartis division Sandoz has concluded the acquisition of global brand rights fo...

Janssen submits sBLA to FDA for NSCLC combination therapy

The Janssen has submitted a sBLA to the US FDA for RYBREVANT plus chemotherapy f...

GC Biopharma and Eubiologics enter deal to produce chol...

GC Biopharma has signed a memorandum of understanding (MOU) with Eubiologics to ...

Labeling Excellence: The Art and Science Behind Capmati...

Delve into Capmatic's advanced labeling solutions, where precision meets creativ...

STAT+: Abortion policy in the spotlight, DeSantis’ impo...

GOP candidates debated over just how far the party should go on national abortio...

STAT+: Vivek Ramaswamy’s brashness made waves in the Re...

Vivek Ramaswamy’s brashness made waves in the Republican debate — much as it did...

STAT+: Republican presidential candidates spar over abo...

Republican presidential candidates sparred Wednesday over a controversial questi...

Wegovy can reduce heart failure symptoms in obese patie...

Novo Nordisk is eyeing the cardiology treatment space for its highly sought-afte...

Pfizer’s first-ever bispecific antibody Elrexfio holds ...

The US Food and Drug Administration's recent accelerated approval of Pfizer's El...

Novo Nordisk engages Thermo Fisher to produce weight-lo...

Novo Nordisk has engaged Thermo Fisher as a contract manufacturer to produce the...

FDA grants clearance to Gilead Sciences’ sNDA for Veklury

The US Food and Drug Administration (FDA) has granted clearance to Gilead Scienc...

Signal: NHS whistle-blower policy questioned following ...

In light of the conviction of UK nurse Lucy Letby for murder, doctors are callin...

Five ways to build trust in patient data sharing

Patient data sharing among various stakeholders for research purposes forms the ...

Merck and AstraZeneca receive approval for Lynparza in ...

Merck (MSD) and AstraZeneca have received approval in Japan for Lynparza to trea...

FDA approves the first Tysabri biosimilar for MS and Cr...

The Sandoz biosimilar, Tyruko, was approved by the US FDA for all labelled indic...